Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Molecular Templates | MTEM | Sep 30, 2024 | 1.41 | -0.35 |
Moleculin Biotech | MBRX | Sep 30, 2024 | 2.84 | +3.27 |
Molina Healthcare | MOH | Sep 30, 2024 | 344.56 | +0.79 |
Molson Coors B | TAP | Sep 30, 2024 | 57.52 | +1.21 |
Molson Coors Beverage Company A | TAP-A | Sep 30, 2024 | 58.26 | 0.00 |
Momentus A | MNTS | Sep 30, 2024 | 0.44 | +2.72 |
Monarch Casino & Resort | MCRI | Sep 30, 2024 | 79.27 | +0.44 |
Monday.com | MNDY | Sep 30, 2024 | 277.77 | +2.13 |
Mondee | MOND | Sep 30, 2024 | 1.39 | -0.71 |
Mondelez International A | MDLZ | Sep 30, 2024 | 73.67 | -0.71 |
Moneyhero | MNY | Sep 30, 2024 | 1.09 | -0.91 |
MoneyLion A | ML | Sep 30, 2024 | 41.55 | +2.87 |
MongoDB A | MDB | Sep 30, 2024 | 270.35 | +0.30 |
Monogram Technologies | MGRM | Sep 30, 2024 | 2.65 | 0.00 |
Monolithic Power Systems | MPWR | Sep 30, 2024 | 924.50 | -0.05 |
Monopar Therapeutics | MNPR | Sep 30, 2024 | 6.74 | -0.44 |
Monro | MNRO | Sep 30, 2024 | 28.86 | +0.07 |
Monroe Capital | MRCC | Sep 30, 2024 | 8.08 | -1.22 |
Monster Beverage | MNST | Sep 30, 2024 | 52.17 | -0.55 |
Montana Technologies A | AIRJ | Sep 30, 2024 | 5.80 | -2.52 |
Montauk Renewables | MNTK | Sep 30, 2024 | 5.21 | -1.88 |
Monte Rosa Therapeutics | GLUE | Sep 30, 2024 | 5.30 | +2.51 |
Montrose Environmental Group | MEG | Sep 30, 2024 | 26.30 | -3.63 |
Moodys | MCO | Sep 30, 2024 | 474.59 | +0.23 |
Moog A | MOG-A | Sep 30, 2024 | 202.02 | +0.61 |
Moog B | MOG-B | Sep 30, 2024 | 198.29 | 0.00 |
Moolec Science | MLEC | Sep 30, 2024 | 0.88 | +2.07 |
MoonLake Immunotherapeutics | MLTX | Sep 30, 2024 | 50.42 | +2.06 |
Morgan Stanley | MS | Sep 30, 2024 | 104.24 | +0.12 |
Morgan Stanley China A Share Fund | CAF | Sep 30, 2024 | 13.54 | +3.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.